BSE Small Cap PB	3.6
BSE Small Cap PE	32.5
BSE Small Cap DIV	0.6
BSE Small Cap EPS	1,594.1

BSE Small Cap News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on BSE Small Cap from all sources in a single place.

Load latest

Schneider Electric Infrastructure Ltd.

26 Nov 2025

761.25

1.27%

Company Update

Schneider Electric Infrastructure Ltd - 534139 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations & …

BSE India

Please find attached intimation pursuant to regulation 30 informing about the receipt of Order from GST Department.

pdf

Apollo Micro Systems Ltd.

26 Nov 2025

271.40

-3.19%

Company Update

Apollo Micro Systems Ltd - 540879 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Investor Meet Intimation

pdf

Intellect Design Arena Ltd.

26 Nov 2025

1090.60

-0.53%

Company Update

Intellect Design Arena Ltd - 538835 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Allotment of 72,331 Equity Shares under Associate (Employees) Stock Option Plan.

pdf

Tinna Rubber and Infrastructure Ltd.

26 Nov 2025

824.00

-1.73%

Company Update

Tinna Rubber and Infrastructure Ltd - 530475 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Tinna Rubber And Infrastructure Limited have scheduled an investor meet to be held on Friday, November 28, 2025

pdf

Zydus Wellness Ltd.

26 Nov 2025

417.05

-2.00%

Zydus Lifesciences, RK Pharma sign deal for licensing, commercialisation

Business Standard

Zydus Lifesciences Ltd on Wednesday said it has entered into an exclusive licensing and commercialisation agreement with RK Pharma Inc of the US for a new sterile injectable oncology supportive care product for the US market. Under the terms of this agreement, RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA (new drug application) submission and commercialisation of the product in the US, the company said in a regulatory filing. The product is expected to be filed in 2026 and will provide a formulation that is intended to provide reduced dosing error and enhanced compliance of healthcare professionals, it added. "This partnership reinforces our commitment to delivering high-quality, affordable medicines and improving patient care," Zydus Lifesciences Managing Director Sharvil Patel said. RK Pharma Founder and Executive Chairman Ravishanker Kovi said, "Our collaboration with Zydus, a company with robust regulatory expertise and